Table 2.
Overview of of studies on ultrasound-guided FUS ablation of breast tumours
| Study | Tumours (n) | Breast tumour characteristics | Outcome of the ablation procedure | |
|---|---|---|---|---|
| 1 | Wu et al. (2003)* [36] | 23 | - Invasive breast cancer, not specified (n = 21) | - Surgical resection |
| - Non-invasive breast cancer, not specified (n = 2) | - Complete necrosis in 23 lesions (100%) | |||
| - All tumours <6 cm in size | - Only TTC staining used | |||
| 2 | Wu et al. (2005) [33] | 23 | - Invasive breast cancer, not specified (n = 21) | - No surgical resection |
| - Non-invasive breast cancer, not specified (n = 1) | - Follow-up range 3–60 months | |||
| - Missing (n = 1) | - Complete necrosis initially (2 weeks) in 23 lesions (100%) | |||
| - All tumours <5 cm in size | - Local recurrence (after 18 and 22 months, respectively) in two lesions (9%) | |||
| 3 | Wu et al. (2007)* [30] | 23 | - Invasive breast cancer, not specified (n = 21) | - Surgical resection |
| - Non-invasive breast cancer, not specified (n = 2) | - Complete necrosis in 23 lesions (100%) | |||
| - All tumours <6 cm in size | - Only TTC staining used |
*Both studies report on the same patient population treated with US-guided FUS